drugset / Trial / NCT03071081
Study for Safety and Tolerability of TOP1288 Administered Orally in Healthy Subjects
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study evaluates the safety and tolerability of TOP1288 oral single ascending and multiple doses in healthy subjects.
Timeline
- Start
- 2017-02-08
- Primary completion
- 2017-06-02
- Completion
- 2017-06-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TOP1288 | Small molecule | 200 mg | Oral |
| Subject | TOP1288 | Small molecule | 1 g | Oral |